ArticlebioRxiv : the preprint server for biology2024

Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.

Alexandre Joushomme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.